City

Athens (1)

Daegu (1)

Daejeon (1)

Gwangju (1)

Rochester (1)

Seongnam-si (1)

Seoul (1)

Yangsan (1)

Condition

Calcific Aortic Valve Disease (3)

Aortic Valve Stenosis (1)

Aortic Valve, Calcification of (1)

Overall Status

Recruiting (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Dong-A ST Co., Ltd. (1)

National and Kapodistrian University of Athens (1)

REDNVIA Co., Ltd. (1)

Collaborator

Biomedical Research Foundation of the Academy of Athens (1)

University of Oxford (1)

Intervention

computerized tomography aortic valve calcium score (1)

da-1229 (1)

echocardiography (1)

evogliptin (1)

multiplex elisa (1)

placebo (1)

targeted lc/ms and lc-ms/ms (1)

untargeted lc/ms and lc-ms/ms (1)

Study Documents

Intervention Type

drug (2)

diagnostic test (1)

other (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Observational (1)

Calcific Aortic Valve Disease

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Calcific Aortic Valve Disease Trial in Rochester (Evogliptin, Placebo)

Recruiting

Calcific Aortic Valve Disease

Evogliptin
Placebo

Rochester, Minnesota

Mayo Clinic

Aug 9, 2022

Serum and Cellular Biomarkers for Aortic Valve Stenosis

Recruiting

Calcific Aortic Valve Disease
+2 more

Echocardiography
+4 more

Athens, Attiki, Greece

First Department of Cardiology, University of Athens, Medical Sc

Mar 21, 2022

Calcific Aortic Valve Disease Trial in Korea, Republic of (DA-1229)

Active, not recruiting

Calcific Aortic Valve Disease

DA-1229

Seongnam-si, Bundang-gu, Korea, Republic of
+9 more

Aug 22, 2021